Seeking Alpha

Protalix BioTherapeutics, Inc (PLX)

There are 3 articles on this stock available only to PRO subscribers.
From other sites
Visit Seeking Alpha's
PLX vs. ETF Alternatives
Company Description
Protalix BioTherapeutics, Inc. is a biopharmaceutical company engaged in the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system.
Sector: Healthcare
Industry: Biotechnology
Country: United States